Grand Medical (Europe)

Galileilaan 15

2845 Niel

BE

Grand Medical (Europe)

Foundation date

16/04/2021

Sector

#Pharma

Subsector

Therapeutic areas

Grand Medical Europe (GME) is a newly established Belgian subsidiary of China Grand Pharmaceutical & Healthcare Holdings Limited (CGP). CGP ranks among China top Pharma and develops products and medical devices in respiratory, cardio/cerebrovascular, antiviral, anti-infection, oncology, ophthalmology, ENT, amino acids, CNS fields. GME is focusing on R&D collaboration with Belgian & European institutions and wishes to explore commercial cooperation with companies interested in the Chinese market.

Upcoming events

Latest news

  • Latest field trials validate strength of Biotalys’ first biocontrol Evoca

    Thursday May 19th 2022

  • Belgian biotech in European Top-3 despite turbulent times

    Wednesday May 18th 2022

  • KU Leuven announces collaboration and license agreement with Gilead Sciences for the development of new antivirals against the respiratory syncytial virus

    Wednesday May 18th 2022